Key statistics
As of last trade, Alterity Therapeutics Ltd (PBN:HAM) traded at 0.001, 100.00% above the 52 week low of 0.0005 set on Aug 30, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.001 |
---|---|
High | 0.001 |
Low | 0.001 |
Bid | 0.001 |
Offer | 0.003 |
Previous close | 0.001 |
Average volume | 0.00 |
---|---|
Shares outstanding | 5.32bn |
Free float | 5.13bn |
P/E (TTM) | -- |
Market cap | 15.96m AUD |
EPS (TTM) | -0.0052 AUD |
Data delayed at least 15 minutes, as of Nov 11 2024 16:25 GMT.
More ▼
Announcements
- Alterity Therapeutics Announces New Publication Describing Novel Mechanism of Action for ATH434
- Appendix 4C – Q1 FY25 Quarterly Cash Flow Report
- Alterity Therapeutics to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit on 17 October 2024
- Alterity Therapeutics Announces Presentation of New Data Describing Neuroprotection of ATH434 at Neuroscience Meeting
- Alterity Therapeutics Raises Profile with Multiple Data Presentations at the International Congress of Parkinson’s Disease and Movement Disorders®
- Alterity Therapeutics Appoints Abby Macnish Niven as Chief Financial Officer
- Alterity Therapeutics to Deliver Multiple Oral and Poster Presentations at the International Congress of Parkinson’s Disease and Movement Disorders®
- Appendix 4C – Q4 FY24 Quarterly Cash Flow Report
- Alterity Therapeutics to Present at MST Financial Webinar
- Alterity Therapeutics Reports Positive Interim Data from ATH434-202 Phase 2 Clinical Trial in Multiple System Atrophy
More ▼